Thyrocare acquires Vimta Labs' diagnostics business in Southern India for Rs 7 crore.

Thyrocare Technologies Ltd acquires Vimta Labs' diagnostic and pathological services business for Rs 7 crore, expanding its presence in Southern India and servicing a larger customer base. The deal aims to increase Thyrocare's market share, strengthen its South India leadership position, and provide high-quality, affordable diagnostic services. Vimta Labs, focused on its core businesses, believes the divestment enhances operating efficiencies.

August 30, 2024
138 Articles